U.S. Centers for Disease Control and Prevention (CDC) educational materials are displayed at a hearing of a House Foreign Affairs subcommittee, about the Ebola crisis in West Africa, on Capitol Hill in Washington August 7, 2014. REUTERS/Jonathan Ernst
WASHINGTON (Reuters) - The U.S. government will not renew funding for a major research project into Lassa fever, a decision that will, in turn, cut resources for a facility in Sierra Leone that is at the forefront of the current battle against the Ebola virus.
The National Institutes of Health rejected a proposal from New Orleans-based Tulane University to renew the five-year contract which expires in November, according to a July 30 letter from NIH reviewed by Reuters. The expiring contract is worth $15 million.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
